Medtronic Inc. CEDEAR (MDT)
BCBA
35,520.00
+1,120.00 (+3.26%)
Closed
Oct 8, 2026
Day's Range
35,020.0035,540.00
52 wk Range
27,380.0041,500.00
Financial Statements - MDT - Medtronic Inc. CEDEAR
Revenue
36.36B▲ 8.4%
Net Income
4.83B▲ 3.1%Net Margin 13.3%
EBITDA
10.17B▲ 3.8%
Free Cash Flow
5.42B▲ 4.6%
Income Statement
| Period Ending | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|---|---|
| Sales | 36.36B | 33.53B | 32.36B | 31.22B | 31.68B | 30.11B |
| Cost of Goods | 12.72B | 11.63B | 11.21B | 10.71B | 10.14B | 10.48B |
| Gross Profit | 23.64B | 21.90B | 21.14B | 20.50B | 21.54B | 19.63B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 6.82B | 6.54B | 5.52B | 5.83B | 5.90B | 4.89B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 22M | -182M | 37M | 170M | 163M | -75M |
| Pre Tax Income | 6.13B | 5.62B | 4.83B | 5.36B | 5.51B | 3.89B |
| Income Tax | 1.29B | 936M | 1.13B | 1.58B | 456M | 265M |
| Net Income | 4.83B | 4.69B | 3.70B | 3.78B | 5.06B | 3.63B |
| EPS Basic | 7.5 | 7.26 | 5.54 | 5.66 | 7.5 | 5.36 |
| EPS Diluted | 7.46 | 7.22 | 5.52 | 5.64 | 7.46 | 5.32 |
| Basic Shares Outstanding | 640.90M | 642.80M | 663.85M | 629.63K | 635.60K | 636.78K |
| Diluted Shares Outstanding | 640.90M | 642.80M | 663.85M | 629.63K | 635.60K | 636.78K |
| Ebit | 6.85B | 6.35B | 5.55B | 6B | 6.07B | 4.82B |
| Ebitda | 10.17B | 9.80B | 8.57B | 9.04B | 8.93B | 7.93B |
| Net Income Continuous Operations | 4.83B | 4.69B | 3.70B | 3.78B | 5.06B | 3.63B |
| Minority Interests | -37M | -29M | -28M | -26M | -22M | -24M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
